Cargando…

Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes

Detalles Bibliográficos
Autores principales:	Ardestani, Amin, Tremblay, Matthew S., Shen, Weijun, Maedler, Kathrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895035/ https://www.ncbi.nlm.nih.gov/pubmed/31815004 http://dx.doi.org/10.1038/s41420-019-0232-0

Ejemplares similares

PHLPP1 deletion restores pancreatic β-cell survival and normoglycemia in the db/db mouse model of obesity-associated diabetes
por: Lupse, Blaz, et al.
Publicado: (2022)

MST1 deletion protects β-cells in a mouse model of diabetes
por: Ardestani, Amin, et al.
Publicado: (2022)

Neratinib protects pancreatic beta cells in diabetes
por: Ardestani, Amin, et al.
Publicado: (2019)

Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer
por: Angelis, Vasileios, et al.
Publicado: (2022)

MST1 is a novel regulator of apoptosis in pancreatic beta-cells
por: Ardestani, Amin, et al.
Publicado: (2014)

Deathly triangle for pancreatic β-cells: Hippo pathway-MTORC1-autophagy
por: Ardestani, Amin, et al.
Publicado: (2021)

mTORC in β cells: more Than Only Recognizing Comestibles
por: Maedler, Kathrin, et al.
Publicado: (2017)

Loss of Deubiquitinase USP1 Blocks Pancreatic β-Cell Apoptosis by Inhibiting DNA Damage Response
por: Gorrepati, Kanaka Durga Devi, et al.
Publicado: (2018)

An SCF(FBXO28) E3 Ligase Protects Pancreatic β-Cells from Apoptosis
por: Gorrepati, Kanaka Durga Devi, et al.
Publicado: (2018)

Commentary: A Human Pluripotent Stem Cell-Based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
por: Ardestani, Amin, et al.
Publicado: (2020)

The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib
por: Booth, Laurence, et al.
Publicado: (2019)

Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes
por: Dharmadhikari, Gitanjali, et al.
Publicado: (2017)

Neratinib for breast cancer
Publicado: (2019)

The Hippo kinase LATS2 impairs pancreatic β-cell survival in diabetes through the mTORC1-autophagy axis
por: Yuan, Ting, et al.
Publicado: (2021)

Loss of Merlin/NF2 protects pancreatic β-cells from apoptosis by inhibiting LATS2
por: Yuan, T, et al.
Publicado: (2016)

Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus
por: Wang, Junjie, et al.
Publicado: (2023)

Deletion of the Mitochondrial Flavoprotein Apoptosis Inducing Factor (AIF) Induces β-Cell Apoptosis and Impairs β-Cell Mass
por: Schulthess, Fabienne T., et al.
Publicado: (2009)

Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes
por: Lupse, Blaz, et al.
Publicado: (2021)

β-MSCs: successful fusion of MSCs with β-cells results in a β-cell like phenotype
por: Azizi, Zahra, et al.
Publicado: (2016)

Mst1 and Mst2 kinases: regulations and diseases
por: Qin, Funiu, et al.
Publicado: (2013)

Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes
por: Shah, Payal, et al.
Publicado: (2016)

Correction: Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes
por: Shah, Payal, et al.
Publicado: (2023)

SGLT2 inhibitors and renal complications in type 1 diabetes
por: Petrie, John R
Publicado: (2020)

SARS-CoV-2 and pancreas: a potential pathological interaction?
por: Geravandi, Shirin, et al.
Publicado: (2021)

Effect of Inactivation of Mst1 and Mst2 in the Mouse Adrenal Cortex
por: Abou Nader, Nour, et al.
Publicado: (2022)

Pancreatic β-cell regeneration: advances in understanding the genes and signaling pathways involved
por: Afelik, Solomon, et al.
Publicado: (2017)

Offline: Restoring trust in WHO
por: Horton, Richard
Publicado: (2020)

Restoring indigenous names in taxonomy
por: Gillman, Len Norman, et al.
Publicado: (2020)

Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation
por: Li, Peng, et al.
Publicado: (2013)

Mst1 and Mst2 Are Essential Regulators of Trophoblast Differentiation and Placenta Morphogenesis
por: Du, Xingrong, et al.
Publicado: (2014)

Raman Microspectroscopic Evidence for the Metabolism of a Tyrosine Kinase Inhibitor, Neratinib, in Cancer Cells
por: Aljakouch, Karim, et al.
Publicado: (2018)

Lung Surfactant for Pulmonary Barrier Restoration in Patients With COVID-19 Pneumonia
por: Mirastschijski, Ursula, et al.
Publicado: (2020)

Crying wolf: concluding that wolves were not restored
por: Mech, L. David
Publicado: (2008)

Transcriptome analysis of neratinib treated HER2 positive cancer model vs untreated cancer unravels the molecular mechanism of action of neratinib
por: Alkhezayem, Sara, et al.
Publicado: (2020)

Minimal invasive microscopic tooth preparation in esthetic restoration: a specialist consensus
por: Yu, Haiyang, et al.
Publicado: (2019)

Integrating open science and multiculturalism to restore trust in psychology
por: Lui, P. Priscilla
Publicado: (2022)

Profile of neratinib and its potential in the treatment of breast cancer
por: Feldinger, Katharina, et al.
Publicado: (2015)

Neratinib-Induced Duodenal Ulcer: A Case Report
por: Moftakhar, Bahar, et al.
Publicado: (2020)

The kinases Mst1 and Mst2 positively regulate phagocyte ROS induction and bactericidal activity
por: Geng, Jing, et al.
Publicado: (2015)

Computational identification of disulfiram and neratinib as putative SARS-CoV-2 main protease inhibitors
por: Stroylov, Victor S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u87tlmtrsdrut4jfh1k5fb1cui